Lumos Pharma Inc (LUMO)
2.26
-0.13
(-5.44%)
USD |
NASDAQ |
Jun 17, 16:00
2.26
0.00 (0.00%)
After-Hours: 19:31
Lumos Pharma Cash from Investing (TTM): 14.20M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 14.20M |
December 31, 2023 | 10.74M |
September 30, 2023 | -6.788M |
June 30, 2023 | -12.74M |
March 31, 2023 | -13.82M |
December 31, 2022 | -11.36M |
September 30, 2022 | -0.03M |
June 30, 2022 | -0.03M |
March 31, 2022 | -0.03M |
December 31, 2021 | 25.97M |
September 30, 2021 | 25.99M |
June 30, 2021 | 58.48M |
March 31, 2021 | 58.47M |
December 31, 2020 | 116.65M |
September 30, 2020 | 116.66M |
June 30, 2020 | 84.16M |
March 31, 2020 | 84.18M |
December 31, 2019 | -0.002M |
September 30, 2019 | 0.006M |
June 30, 2019 | 0.016M |
March 31, 2019 | 0.034M |
December 31, 2018 | 0.117M |
September 30, 2018 | 0.18M |
June 30, 2018 | 0.197M |
March 31, 2018 | 0.307M |
Date | Value |
---|---|
December 31, 2017 | 0.211M |
September 30, 2017 | -0.035M |
June 30, 2017 | -0.147M |
March 31, 2017 | -0.981M |
December 31, 2016 | -0.066M |
September 30, 2016 | 0.602M |
June 30, 2016 | 0.396M |
March 31, 2016 | 3.235M |
December 31, 2015 | 6.218M |
September 30, 2015 | 9.614M |
June 30, 2015 | -7.529M |
March 31, 2015 | -9.866M |
December 31, 2014 | -13.84M |
September 30, 2014 | -18.09M |
June 30, 2014 | -1.409M |
March 31, 2014 | -0.919M |
December 31, 2013 | -0.141M |
September 30, 2013 | 1.273M |
June 30, 2013 | 0.015M |
March 31, 2013 | 1.067M |
December 31, 2012 | -0.277M |
September 30, 2012 | -4.013M |
June 30, 2012 | -1.788M |
March 31, 2012 | -1.382M |
December 31, 2011 | -0.502M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-13.82M
Minimum
Mar 2023
116.66M
Maximum
Sep 2020
27.54M
Average
5.379M
Median
Cash from Investing (TTM) Benchmarks
icad Inc | 3.191M |
Perspective Therapeutics Inc | -48.19M |
Palatin Technologies Inc | 9.41M |
Bio-Path Holdings Inc | -- |
PDS Biotechnology Corp | -- |